权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Elucidating a microgliaassociated role for SORLA in modulating AD pathogenesis

阐明 SORLA 在调节 AD 发病机制中的小胶质细胞相关作用

基本信息

批准号：
10455261
负责人：
Timothy Yikai Huang
金额：
$ 281.85万
依托单位：
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
依托单位国家：
美国
项目类别：
财政年份：
2022
资助国家：
美国
起止时间：
2022-08-01 至 2025-07-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10455261
关键词：
Abeta clearance Affect Alleles Alzheimer&apos s Disease Alzheimer&apos s disease brain Alzheimer&apos s disease model Alzheimer&apos s disease risk Amyloid beta-Protein Amyloid beta-Protein Precursor Behavior Biological Assay Brain CRISPR/Cas technology Cell Line Cells Coculture Techniques Defect Disease ES Cell Line Early Onset Alzheimer Disease Epigenetic Process Functional disorder Gene Expression Gene Expression Profile Generations Genes Glial Differentiation Gliosis Hematopoietic stem cells Histology Homeostasis Human Impairment In Vitro Label Late Onset Alzheimer Disease Link Location Mediating Methods Microdialysis Microglia Modeling Mus Mutation Nature Neurons Newborn Infant Pathogenesis Pathogenicity Pathologic Pathway interactions Peptides Play Proteomics Recombinants Role Senile Plaques Synapses System TREM2 gene Testing Up-Regulation Variant Xenograft Model Xenograft procedure age related behavior in vitro cytokine embryonic stem cell exome sequencing extracellular gain of function genetic signature genome wide association study human embryonic stem cell human embryonic stem cell line in vivo insight mouse model mutant nano-string neglect neuroinflammation proteotoxicity pup receptor risk variant sortilin trafficking transcriptome sequencing transcriptomics uptake

项目摘要

PROJECT SUMMARY Mutations in SORLA (encoded by SORL1) identified through GWAS and whole exome sequencing analysis have been linked to increased Alzheimer’s disease (AD) risk. Although a neuronal role for SORLA in suppressing amyloidogenic APP processing and consequent Aβ generation has been established, SORLA expression is ~8-fold higher in human microglia compared to neurons, thus implicating a microglial role for SORLA in AD pathogenesis. So far, functional roles for SORLA in microglia have not yet been described. Here, we used CRISPR/Cas9 editing methods to integrate AD-associated A528T and R744X mutations into the SORL1 (encoding SORLA) locus in human H9 embryonic stem cells, which were subsequently differentiated into human microglia-like (hMGL) cells. Comparing transcriptomic profiles between wildtype and AD-associated SORL1 (A528T, R744X) and TREM2 (R47H) mutant hMGLs reveals pathogenic microglia gene signatures such as induced APOE expression previously described in AD mouse models and human AD brain. Our results also show that cultured SORL1R744X and TREM2R47H hMGLs feature defects in Aβ uptake in an APOE-dependent manner, along with impaired Aβ clearance and plaque association in mouse brain xenotransplants by microdialysis/histology. These results provide pioneering evidence that SORLA dysfunction can confer pathogenic expression signatures and impair microglial function. We hypothesize that microglial dysfunction will vary according to domain-specific mutations in the SORLA extracellular region, and that early and late onset SORLA mutations may show differential effects on microglia dysregulation and microglia/neuron interaction. Using our gene editing/human microglial modeling and analysis platform, we will expand our SORLA mutant embryonic stem cell (ESC) panel to include representative early and late AD onset mutations within each of the functional domains in the SORLA extracellular region. We will characterize gene expression profiles of wildtype (WT) and SORLA mutant ESC-derived microglia (“xhMGs”) in vivo by RNAseq/proteomic analysis, as well as functional aspects of microglial function (Aβ uptake, cytokine profiles) in xhMGs xenotransplanted in AD mouse brain. As our results indicate that SORLA mutations such as R744X and A528T upregulate APOE which may trigger certain aspects of microglia function, we will also test whether APOE and other potential drivers of microglia dysfunction epistatically mediate downstream pathogenic behavior in SORLA mutant microglia xenotransplants in AD mouse brain. We will also explore cellular mechanisms associated with various SORLA mutations that drive cellular dysfunction in ESC-derived microglia and neurons; to this end, we will investigate how SORLA mutations in human microglia (xhMGs) interact with neurons in mouse AD brain xenotransplants, as well as WT and SORLA mutant hMGLs/neurons in co-culture. These results will provide us with mechanistic insight into how various mutations can trigger microglia dysfunction, and potentially describe how aspects of microglial and neuronal-related SORLA pathways are affected to alter age-related onset in AD pathogenesis.

项目总结